Participant flow

Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant · Source last updated 2016-02-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia

   id

   FG000

   title

   HLA Haploidentical Natural Killer Cell Infusion

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         6

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         6

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice